Wellington Management Group LLP Mirati Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$531 Billion
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$27.8 - $45.35 $1.9 Million - $3.1 Million	-68,443 Reduced 2.02%	3,319,922 $145 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $25 Million - $34.3 Million	692,273 Added 25.68%	3,388,365 $122 Million
Q1 2023 May 12, 2023	SELL	$36.54 - $54.26 $11.7 Million - $17.4 Million	-320,243 Reduced 10.62%	2,696,092 $100 Million
Q4 2022 Feb 13, 2023	SELL	$41.27 - $98.62 $18.7 Million - $44.7 Million	-452,976 Reduced 13.06%	3,016,335 $137 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $33.5 Million - $48.8 Million	563,281 Added 19.38%	3,469,311 $242 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $16.6 Million - $37.6 Million	423,509 Added 17.06%	2,906,030 $195 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $50.4 Million - $100 Million	-664,294 Reduced 21.11%	2,482,521 $204 Million
Q4 2021 Feb 11, 2022	SELL	$132.01 - $190.29 $38.7 Million - $55.8 Million	-293,407 Reduced 8.53%	3,146,815 $462 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $44.5 Million - $59.8 Million	336,737 Added 10.85%	3,440,222 $609 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $132 Million - $165 Million	917,067 Added 41.94%	3,103,485 $501 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $10.9 Million - $15.2 Million	-68,464 Reduced 3.04%	2,186,418 $375 Million
Q4 2020 Feb 12, 2021	BUY	$162.05 - $240.27 $100 Million - $148 Million	617,462 Added 37.71%	2,254,882 $495 Million
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $18.9 Million - $28 Million	-167,281 Reduced 9.27%	1,637,420 $272 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $4.95 Million - $8.28 Million	68,744 Added 3.96%	1,804,701 $206 Million
Q1 2020 May 14, 2020	BUY	$69.78 - $116.21 $79.6 Million - $133 Million	1,140,777 Added 191.67%	1,735,957 $133 Million
Q4 2019 Feb 11, 2020	BUY	$70.76 - $128.86 $42.1 Million - $76.7 Million	595,180 New	595,180 $76.7 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account